Financial Results : AYYAN loses SAR 164.4M in 2024, SAR 25.8M in Q4

AYYAN loses SAR 164.4M in 2024, SAR 25.8M in Q4

06/03/2025 Argaam Exclusive

View other reports

AYYAN Investment Co. narrowed its losses to SAR 164.4 million in 2024, from SAR 216.3 million a year earlier.



Financials (M)

Item 2023 2024 Change‬
Revenues 23.91 23.15 (3.2 %)
Gross Income 7.49 10.16 35.6 %
Operating Income (4.80) (5.42) (12.8 %)
Net Income (216.30) (164.41) 24.0 %
Average Shares 88.35 100.64 13.9 %
Earnings Per Share before unusual items (Riyals) (2.45) (1.63) 33.3 %
EPS (Riyal) (2.45) (1.63) 33.3 %

This came as losses from discontinued operations contracted, driven by lower losses at Al-Salam Medical Services Co., as Al-Salam Hospital’s revenue surged to SAR 196.5 million in 2024, from SAR 50.8 million in 2023. This was supported by higher patient volumes and improved operational efficiency.

 

This, along with lower cost of revenue, a decline in selling and marketing expenses, and a higher share of profits from an associate company, offset the impact of lower sales volumes in 2024.

 

Notably, all revenue and expenses of Al-Ahsa Medical Services Co. and Al-Salam Medical Services (both subsidiaries) have been classified under discontinued operations, with net results reported accordingly.

 

Comparative figures have also been restated to align with IFRS 5.

 

Q4 2024 net loss reached SAR 25.77 million, down from SAR 71.88 million in Q4 2023.

 

On a sequential basis, AYYAN’s net losses shrank from SAR 34.68 million in Q3 2024.

 

By the end of Dec. 31, 2024, AYYAN’s accumulated losses totaled SAR 410.98 million, representing 40.84% of capital.



Current Quarter Comparison (M)

Compared With The
Item Q4 2023 Q4 2024 Change‬
Revenues 6.00 3.71 (38.2 %)
Gross Income 1.75 1.43 (18.3 %)
Operating Income (3.74) (7.01) (87.3 %)
Net Income (71.94) (25.77) 64.2 %
Average Shares 88.35 100.64 13.9 %
Earnings Per Share before unusual items (Riyal) (0.81) (0.26) 68.5 %
EPS (Riyal) (0.81) (0.26) 68.5 %

Total shareholders’ equity, after minority interest, stood at SAR 606.87 million by Dec. 31, 2024, compared to SAR 500 million a year earlier.



Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
Q1 2015 9.51 1202.9 % 2.66 132900.0 % (0.85) 51.7 %
Q2 2015 47.51 1820.4 % 13.14 2176.6 % (0.32) 66.4 %
Q3 2015 43.30 4157.4 % 10.82 13141.0 % (1.72) 32.9 %
Q4 2015 50.24 1858.1 % 12.67 4989.2 % (0.51) 92.2 %
Q1 2016 49.61 421.6 % 12.71 378.4 % (1.20) (41.8 %)
Q2 2016 49.61 4.4 % 12.68 (3.4 %) (1.11) (243.3 %)
Q3 2016 45.23 4.5 % 13.43 24.1 % (0.80) 53.8 %
Q4 2016 47.48 (5.5 %) 9.52 (24.9 %) (4.28) (733.7 %)
Q1 2017 50.64 2.1 % 12.56 (1.2 %) (1.94) (61.3 %)
Q2 2017 55.45 11.8 % 15.06 18.8 % 0.61 154.7 %
Q3 2017 49.78 10.1 % 12.73 (5.2 %) (1.10) (38.4 %)
Q4 2017 53.20 12.0 % 12.54 31.8 % (4.73) (10.7 %)
Q1 2018 53.02 4.7 % 12.41 (1.2 %) (2.51) (29.8 %)
Q2 2018 53.67 (3.2 %) 12.13 (19.5 %) (0.77) (227.0 %)
Q3 2018 57.55 15.6 % 14.21 11.6 % (0.42) 61.9 %
Q4 2018 61.42 15.5 % 13.99 11.5 % (2.18) 54.0 %
Q1 2019 57.62 8.7 % 14.62 17.9 % 0.40 115.8 %
Q2 2019 58.62 9.2 % 14.98 23.5 % (0.66) 14.8 %
Q3 2019 60.26 4.7 % 15.68 10.4 % 0.52 223.6 %
Q4 2019 69.00 12.3 % 24.10 72.3 % (6.56) (201.4 %)
Q1 2020 63.70 10.5 % 16.37 12.0 % 0.53 33.0 %
Q2 2020 65.91 12.4 % 20.93 39.7 % 5.27 901.5 %
Q3 2020 71.50 18.6 % 24.53 56.5 % 7.66 1375.6 %
Q4 2020 67.83 (1.7 %) 19.66 (18.4 %) 1.90 128.9 %
Q1 2021 79.37 24.6 % 28.29 72.8 % 8.71 1545.0 %
Q2 2021 75.01 13.8 % 24.58 17.5 % 1.80 (65.8 %)
Q3 2021 71.37 (0.2 %) 22.17 (9.6 %) 7.65 (0.1 %)
Q4 2021 62.23 (8.3 %) 7.93 (59.7 %) (9.86) (619.9 %)
Q1 2022 88.11 11.0 % 31.64 11.9 % 14.08 61.7 %
Q2 2022 60.41 (19.5 %) 7.50 (69.5 %) (14.00) (878.0 %)
Q3 2022 71.02 (0.5 %) 16.73 (24.5 %) (16.96) (321.8 %)
Q4 2022 57.89 (7.0 %) (27.83) (451.0 %) (29.04) (194.7 %)
Q1 2023 70.34 (20.2 %) (10.75) (134.0 %) (39.06) (377.5 %)
Q2 2023 76.76 27.1 % (2.15) (128.6 %) (36.89) (163.5 %)
Q3 2023 3.21 (95.5 %) (0.99) (105.9 %) (3.00) 82.3 %
Q4 2023 6.00 (89.6 %) 1.75 106.3 % (3.74) 87.1 %
Q1 2024 6.00 (91.5 %) 1.63 115.1 % (0.62) 98.4 %
Q2 2024 6.78 (91.2 %) 3.36 256.2 % 1.02 102.8 %
Q3 2024 6.66 107.5 % 3.75 479.3 % 1.20 139.9 %
Q4 2024 3.71 (38.2 %) 1.43 (18.3 %) (7.01) (87.3 %)
2024 23.15 (3.2 %) 10.16 35.6 % (5.42) (12.8 %)


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS(Riyal)
Q1 2015 4.74 0.9 % 0.09 2.97 1.77 0.03
Q2 2015 29.26 811.3 % 0.54 2.84 26.42 0.49
Q3 2015 7.56 159.0 % 0.14 23.19 (15.62) (0.29)
Q4 2015 (0.41) 98.2 % (0.01) - (0.41) (0.01)
Q1 2016 (2.79) (158.8 %) (0.05) (1.47) (1.32) (0.02)
Q2 2016 (12.83) (143.8 %) (0.24) (1.75) (11.08) (0.21)
Q3 2016 (2.88) (138.1 %) (0.05) - (2.88) (0.05)
Q4 2016 (14.17) (3,382.6 %) (0.26) (13.12) (1.05) (0.02)
Q1 2017 1.00 135.9 % 0.02 - 1.00 0.02
Q2 2017 1.59 112.4 % 0.03 - 1.59 0.03
Q3 2017 (2.11) 26.6 % (0.04) (2.50) 0.39 0.01
Q4 2017 (9.93) 30.0 % (0.18) - (9.93) (0.18)
Q1 2018 (2.79) (378.1 %) (0.05) - (2.79) (0.05)
Q2 2018 0.32 (79.6 %) 0.01 - 0.32 0.01
Q3 2018 1.17 155.4 % 0.02 - 1.17 0.02
Q4 2018 8.51 185.8 % 0.16 - 8.51 0.16
Q1 2019 1.42 151.0 % 0.03 - 1.42 0.03
Q2 2019 1.98 510.8 % 0.04 - 1.98 0.04
Q3 2019 2.30 96.8 % 0.04 - 2.30 0.04
Q4 2019 (6.88) (180.9 %) (0.13) - (6.88) (0.13)
Q1 2020 15.91 1020.3 % 0.20 14.58 1.33 0.02
Q2 2020 3.96 100.0 % 0.05 - 3.96 0.05
Q3 2020 9.19 299.2 % 0.11 3.01 6.18 0.08
Q4 2020 (1.76) 74.4 % (0.02) - (1.76) (0.02)
Q1 2021 7.37 (53.7 %) 0.09 - 7.37 0.09
Q2 2021 0.62 (84.5 %) 0.01 - 0.62 0.01
Q3 2021 3.74 (59.4 %) 0.05 - 3.74 0.05
Q4 2021 (7.42) (321.2 %) (0.09) - (7.42) (0.09)
Q1 2022 13.42 82.1 % 0.15 - 13.42 0.15
Q2 2022 (11.73) (2006.5 %) (0.13) - (11.73) (0.13)
Q3 2022 (16.75) (548.4 %) (0.19) - (16.75) (0.19)
Q4 2022 (29.71) (300.2 %) (0.34) - (29.71) (0.34)
Q1 2023 (46.65) (447.7 %) (0.53) - (46.65) (0.53)
Q2 2023 (41.29) (252.1 %) (0.47) - (41.29) (0.47)
Q3 2023 (56.43) (236.9 %) (0.64) - (56.43) (0.64)
Q4 2023 (71.94) (142.2 %) (0.81) - (71.94) (0.81)
Q1 2024 (55.65) (19.3 %) (0.63) - (55.65) (0.63)
Q2 2024 (48.30) (17.0 %) (0.55) - (48.30) (0.55)
Q3 2024 (34.68) 38.5 % (0.34) - (34.68) (0.34)
Q4 2024 (25.77) 64.2 % (0.26) - (25.77) (0.26)
2024 (164.41) 24.0 % (1.63) - (164.41) (1.63)

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2015 21.83 % (65.06 %) 75.87 %
Q2 2015 26.33 % (17.50 %) 69.87 %
Q3 2015 26.11 % (6.83 %) 5.79 %
Q4 2015 26.09 % 4.77 % 8.07 %
Q1 2016 25.88 % 5.37 % 4.76 %
Q2 2016 25.36 % 6.95 % (14.75 %)
Q3 2016 26.45 % 8.29 % (8.05 %)
Q4 2016 25.18 % 4.00 % (8.51 %)
Q1 2017 24.97 % 4.40 % (7.26 %)
Q2 2017 25.44 % 4.43 % (0.68 %)
Q3 2017 24.52 % 4.39 % 0.95 %
Q4 2017 25.30 % 3.92 % (3.32 %)
Q1 2018 24.94 % 2.88 % (5.08 %)
Q2 2018 23.76 % 2.89 % (5.72 %)
Q3 2018 23.59 % 3.08 % (5.16 %)
Q4 2018 23.37 % 3.99 % 3.20 %
Q1 2019 23.86 % 5.12 % 4.96 %
Q2 2019 24.57 % 2.19 % 5.56 %
Q3 2019 24.91 % 5.57 % 5.97 %
Q4 2019 28.26 % 3.64 % (0.48 %)
Q1 2020 28.27 % 3.58 % (0.51 %)
Q2 2020 29.78 % 8.46 % 0.27 %
Q3 2020 31.81 % 8.26 % 1.70 %
Q4 2020 30.30 % 11.71 % 3.61 %
Q1 2021 32.82 % 14.04 % 5.53 %
Q2 2021 33.04 % 12.47 % 4.22 %
Q3 2021 32.26 % 12.58 % 3.39 %
Q4 2021 28.81 % 8.91 % 1.49 %
Q1 2022 29.09 % 10.51 % 3.49 %
Q2 2022 24.55 % 5.61 % (0.71 %)
Q3 2022 22.64 % (3.14 %) (7.98 %)
Q4 2022 10.11 % (8.78 %) (16.14 %)
Q1 2023 (5.52 %) (28.09 %) (40.37 %)
Q2 2023 (8.69 %) (32.82 %) (48.69 %)
Q3 2023 (20.04 %) (33.79 %) (83.61 %)
Q4 2023 (7.76 %) (27.85 %) (138.39 %)
2023 31.32 % 143.67 % (904.59 %)
Q1 2024 0.26 % 0.79 % (244.99 %)
Q2 2024 26.11 % 197.30 % (1056.68 %)
Q3 2024 41.19 % 178.72 % (827.90 %)
Q4 2024 43.88 % 147.47 % (710.34 %)
2024 43.88 % 147.47 % (710.34 %)


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Earnings Per Share before unusual items (Riyal) Book Value (BV)
Q1 2015 53.69 (0.64) 0.22 9.28
Q2 2015 53.69 (0.02) 0.79 9.91
Q3 2015 53.69 0.36 0.11 9.67
Q4 2015 53.69 0.77 0.23 9.85
Q1 2016 53.69 0.63 0.17 9.59
Q2 2016 53.69 (0.16) (0.53) 9.34
Q3 2016 53.69 (0.35) (0.29) 9.24
Q4 2016 53.69 (0.61) (0.30) 9.09
Q1 2017 53.69 (0.54) (0.26) 9.08
Q2 2017 53.69 (0.27) (0.03) 9.07
Q3 2017 53.69 (0.26) 0.04 9.09
Q4 2017 53.69 (0.18) (0.13) 8.89
Q1 2018 53.69 (0.25) (0.20) 9.66
Q2 2018 53.69 (0.27) (0.22) 9.72
Q3 2018 53.69 (0.21) (0.21) 9.73
Q4 2018 53.69 0.13 0.13 9.79
Q1 2019 53.69 0.21 0.21 9.76
Q2 2019 53.69 0.24 0.24 9.17
Q3 2019 53.69 0.26 0.26 9.33
Q4 2019 53.69 (0.02) (0.02) 9.63
Q1 2020 80.79 0.16 (0.02) 9.28
Q2 2020 80.79 0.19 0.01 9.34
Q3 2020 80.79 0.27 0.06 9.45
Q4 2020 80.79 0.34 0.12 9.29
Q1 2021 82.68 0.23 0.19 9.38
Q2 2021 82.68 0.19 0.15 9.39
Q3 2021 82.68 0.12 0.12 9.44
Q4 2021 82.68 0.05 0.05 9.15
Q1 2022 88.35 0.12 0.12 9.30
Q2 2022 88.35 (0.02) (0.02) 9.17
Q3 2022 88.35 (0.25) (0.25) 8.98
Q4 2022 88.35 (0.51) (0.51) 8.33
Q1 2023 88.35 (1.19) (1.19) 7.80
Q2 2023 88.35 (1.52) (1.52) 7.33
Q3 2023 88.35 (1.97) (1.97) 6.69
Q4 2023 88.35 (2.45) (2.45) 5.66
Q1 2024 88.35 (2.55) (2.55) 5.01
Q2 2024 88.35 (2.63) (2.63) 4.46
Q3 2024 100.64 (2.09) (2.09) 5.50
Q4 2024 100.64 (1.63) (1.63) 6.03

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Recurring P/E Price/book
Q1 2015 NEG More than 100 2.69
Q2 2015 NEG 35.77 2.85
Q3 2015 51.44 More than 100 1.90
Q4 2015 27.54 93.24 2.14
Q1 2016 35.24 More than 100 2.30
Q2 2016 NEG NEG 2.17
Q3 2016 NEG NEG 1.86
Q4 2016 NEG NEG 2.19
Q1 2017 NEG NEG 2.84
Q2 2017 NEG NEG 2.26
Q3 2017 NEG More than 100 2.33
Q4 2017 NEG NEG 2.32
Q1 2018 NEG NEG 1.99
Q2 2018 NEG NEG 2.02
Q3 2018 NEG NEG 1.77
Q4 2018 More than 100 More than 100 1.74
Q1 2019 83.75 83.75 1.83
Q2 2019 72.46 72.46 1.92
Q3 2019 67.72 67.72 1.92
Q4 2019 NEG NEG 2.00
Q1 2020 65.93 NEG 1.17
Q2 2020 67.79 More than 100 1.37
Q3 2020 65.70 More than 100 1.91
Q4 2020 66.64 More than 100 2.42
Q1 2021 More than 100 More than 100 2.55
Q2 2021 More than 100 More than 100 3.39
Q3 2021 More than 100 More than 100 3.10
Q4 2021 More than 100 More than 100 2.31
Q1 2022 More than 100 More than 100 2.13
Q2 2022 NEG NEG 1.91
Q3 2022 NEG NEG 1.93
Q4 2022 NEG NEG 1.76
Q1 2023 NEG NEG 2.08
Q2 2023 NEG NEG 2.78
Q3 2023 NEG NEG 2.36
Q4 2023 NEG NEG 2.87
Q1 2024 NEG NEG 4.20
Q2 2024 NEG NEG 4.12
Q3 2024 NEG NEG 3.02
Q4 2024 NEG NEG 2.51

Business Segments (Million)

Compared With The
Period Manufacturing, assembly & supply sector medical service Investments Food
Q1 2015 2.59 6.92 - -
Q2 2015 3.43 44.09 - -
Q3 2015 1.75 41.55 - -
Q4 2015 3.15 47.09 - -
Q1 2016 3.10 46.51 - -
Q2 2016 4.04 45.56 - -
Q3 2016 1.51 43.72 - -
Q4 2016 2.81 44.67 - -
Q1 2017 2.67 47.97 - -
Q2 2017 4.98 50.48 - -
Q3 2017 2.91 46.87 - -
Q4 2017 2.59 50.60 - -
Q1 2018 2.78 50.24 - -
Q2 2018 5.45 48.22 - -
Q3 2018 2.73 54.82 - -
Q4 2018 3.75 57.67 - -
Q1 2019 3.91 53.71 - -
Q2 2019 4.17 54.45 - -
Q3 2019 3.62 56.65 - -
Q4 2019 4.75 64.25 - -
Q1 2020 4.85 58.48 - -
Q2 2020 4.01 57.41 - -
Q3 2020 3.74 62.20 - -
Q4 2020 4.18 60.44 - -
Q1 2021 4.95 67.58 - -
Q2 2021 3.77 66.66 - -
Q3 2021 3.57 62.23 - -
Q4 2021 4.63 56.17 - -
Q1 2022 5.59 70.01 - -
Q2 2022 4.03 61.83 - -
Q3 2022 4.22 63.91 - -
Q4 2022 5.42 51.22 - -
Q1 2023 6.52 62.67 - -
Q2 2023 4.25 72.25 - -
Q3 2023 4.31 - - -
Q4 2023 5.01 - - -
Q1 2024 5.17 - 0.83 -
Q2 2024 3.86 - 2.92 -
Q3 2024 3.25 - 3.41 -
Q4 2024 3.16 - 0.54 -

Current
Market Cap (M Riyal) 1,307.31
Enterprise Value (EV) (M Riyal) 524.01
Shares Outstanding ((M)) 100.64
EPS ( Riyal) (TTM) 4.41
Book Value (BV) ( Riyal) 10.69
Par Value ( Riyal) 10.00
Recurring P/E 51.31
P/E (TTM) 2.95
Price/book 1.21
Return on Average Assets (%) (TTM) 32.1
Return on Average Equity (%) (TTM) 54.4
EV/adj EBITDA 5.24
EV/Revenues 4.05

Share Price

12.99
0.06 0.46 %

AYYAN Investment Co. (AYYAN)


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.